Bio-Rad SARS-CoV-2 serology, ddPCR tests granted EUAs

Create PDF

In a separate release, the company announced its SARS-CoV-2 Droplet Digital PCR test kit has been granted emergency use authorization.

“The high sensitivity of the test makes it well suited to screening upper respiratory samples in patients with a low viral load,” the company said in a press release, “including individuals in the early stages of infection as compared to classical quantitative PCR tests. The test can also play an important role in surveillance by detecting minimal residual disease in people recovering from COVID-19 informing them if they are negative for the virus.”

The SARS-CoV-2 ddPCR test runs on Bio-Rad’s QX200 and QXDx ddPCR systems.